- Home
- INTS vs VIVK Comparison
INTS vs VIVK Comparison
Compare INTS & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- VIVK
- Stock Information
- Founded
- INTS 2012
- VIVK 2006
- Country
- INTS United States
- VIVK United States
- Employees
- INTS N/A
- VIVK N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- VIVK Oilfield Services/Equipment
- Sector
- INTS Health Care
- VIVK Energy
- Exchange
- INTS Nasdaq
- VIVK Nasdaq
- Market Cap
- INTS 30.8M
- VIVK 34.6M
- IPO Year
- INTS 2023
- VIVK N/A
- Fundamental
- Price
- INTS $0.54
- VIVK $0.78
- Analyst Decision
- INTS Strong Buy
- VIVK
- Analyst Count
- INTS 3
- VIVK 0
- Target Price
- INTS $8.50
- VIVK N/A
- AVG Volume (30 Days)
- INTS 362.2K
- VIVK 53.5K
- Earning Date
- INTS 05-20-2025
- VIVK 05-19-2025
- Dividend Yield
- INTS N/A
- VIVK N/A
- EPS Growth
- INTS N/A
- VIVK N/A
- EPS
- INTS N/A
- VIVK N/A
- Revenue
- INTS N/A
- VIVK $89,811,240.00
- Revenue This Year
- INTS N/A
- VIVK N/A
- Revenue Next Year
- INTS N/A
- VIVK N/A
- P/E Ratio
- INTS N/A
- VIVK N/A
- Revenue Growth
- INTS N/A
- VIVK 51.40
- 52 Week Low
- INTS $0.50
- VIVK $0.55
- 52 Week High
- INTS $5.28
- VIVK $3.45
- Technical
- Relative Strength Index (RSI)
- INTS 18.34
- VIVK 43.75
- Support Level
- INTS $0.55
- VIVK $0.72
- Resistance Level
- INTS $0.59
- VIVK $1.08
- Average True Range (ATR)
- INTS 0.12
- VIVK 0.11
- MACD
- INTS -0.02
- VIVK -0.02
- Stochastic Oscillator
- INTS 4.71
- VIVK 14.74
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.